Advertisement
Screener

BIOGEN INC. (BIIB) Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

2.8 / 5 stars · 68/120 Roast Me

BIOGEN INC. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

BIOGEN INC. (BIIB) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $3.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-06.

Financial Statements › Shareholders' Equity

us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-02-06

  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2021-12-31 was $0.00.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2021-09-30 was $0.00.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2021-06-30 was $100.00M.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $3.20M.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2021 was $100.00M, a 33.33% increase from fiscal 2020.
  • BIOGEN INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2020 was $75.00M.
Period endNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month as first filedNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month as first filedNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month as first filedNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 monthNoncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month as first filed
2023-12-31$3.20M
10-K · filed 2026-02-06
2022-12-31$0.00
10-K · filed 2023-02-15
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$0.00
derived: sum of 2 quarters · filed 2024-02-14
$100.00M
derived: sum of 3 quarters · filed 2024-02-14
$100.00M
10-K · filed 2024-02-14
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25
$100.00M
derived: sum of 2 quarters · filed 2022-10-25
$100.00M
10-Q · filed 2022-10-25
2021-06-30$100.00M
10-Q · filed 2022-07-20
$100.00M
10-Q · filed 2022-07-20
2020-12-31$75.00M
10-K · filed 2023-02-15
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03
$0.00
derived: sum of 2 quarters · filed 2021-02-03
$50.00M
derived: sum of 3 quarters · filed 2021-02-03
$50.00M
10-K · filed 2021-02-03
2018-09-30$0.00
10-Q · filed 2018-10-23
$50.00M
derived: sum of 2 quarters · filed 2019-07-24
$50.00M
10-Q · filed 2019-10-22
2018-06-30$50.00M
10-Q · filed 2019-07-24
$50.00M
10-Q · filed 2019-07-24
2017-12-31$150.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
$150.00M
derived: sum of 2 quarters · filed 2020-02-06
$150.00M
derived: sum of 3 quarters · filed 2020-02-06
$150.00M
10-K · filed 2020-02-06
2017-09-30$0.00
10-Q · filed 2018-10-23
$0.00
derived: sum of 2 quarters · filed 2018-10-23
$0.00
10-Q · filed 2018-10-23
2017-06-30$0.00
10-Q · filed 2018-07-24
$0.00
10-Q · filed 2018-07-24
2016-12-31$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02
$1.50M
derived: sum of 2 quarters · filed 2017-02-02
$1.50M
10-K · filed 2017-02-02
2016-09-30$0.00
10-Q · filed 2016-10-26
$0.00
10-Q · filed 2016-10-26
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01
$60.00M
derived: sum of 2 quarters · filed 2018-02-01
$60.00M
10-K · filed 2018-02-01
2015-09-30$60.00M
10-Q · filed 2016-10-26
$60.00M
10-Q · filed 2016-10-26
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02
$0.00
derived: sum of 2 quarters · filed 2017-02-02
$9.10M
derived: sum of 3 quarters · filed 2017-02-02
$9.10M
10-K · filed 2017-02-02
$9.05M
10-K · filed 2015-02-04
2014-09-30$0.00
10-Q · filed 2015-10-21
$9.10M
derived: sum of 2 quarters · filed 2015-10-21
$9.10M
10-Q · filed 2015-10-21
-$9.10M
10-Q · filed 2014-10-22
2014-06-30$9.10M
10-Q · filed 2015-07-24
-$9.10M
10-Q · filed 2014-07-23
$9.10M
10-Q · filed 2015-07-24
-$9.10M
10-Q · filed 2014-07-23
2013-09-30$0.00
10-Q · filed 2014-10-22
$0.00
derived: sum of 2 quarters · filed 2014-10-22
$0.00
10-Q · filed 2014-10-22
-$2.50M
derived: sum of 4 quarters · filed 2015-02-04
2013-06-30$0.00
10-Q · filed 2014-07-23
$0.00
10-Q · filed 2014-07-23
-$2.50M
derived: sum of 3 quarters · filed 2015-02-04
-$2.50M
derived: sum of 4 quarters · filed 2015-02-04
2013-03-31$0.00
10-Q · filed 2013-04-25
-$2.50M
derived: sum of 2 quarters · filed 2015-02-04
-$2.50M
derived: sum of 3 quarters · filed 2015-02-04
-$2.50M
derived: sum of 4 quarters · filed 2015-02-04
2012-12-31-$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04
-$2.50M
derived: sum of 2 quarters · filed 2015-02-04
-$2.50M
derived: sum of 3 quarters · filed 2015-02-04
-$1.20M
10-K · filed 2015-02-04
$1.20M
10-K · filed 2013-02-05
2012-09-30$0.00
10-Q · filed 2013-10-28
$0.00
derived: sum of 2 quarters · filed 2013-10-28
$1.30M
10-Q · filed 2013-10-28
-$1.30M
10-Q · filed 2012-10-25
$1.76M
derived: sum of 4 quarters · filed 2014-02-06
2012-06-30$0.00
10-Q · filed 2013-07-25
$1.30M
10-Q · filed 2013-07-25
-$1.30M
10-Q · filed 2012-07-24
$1.76M
derived: sum of 3 quarters · filed 2014-02-06
$15.86M
derived: sum of 4 quarters · filed 2014-02-06
2012-03-31-$1.30M
10-Q · filed 2013-04-25
$1.30M
10-Q · filed 2012-05-01
$1.76M
derived: sum of 2 quarters · filed 2014-02-06
$15.86M
derived: sum of 3 quarters · filed 2014-02-06
$25.76M
derived: sum of 4 quarters · filed 2014-02-06
2011-12-31$3.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06
$17.16M
derived: sum of 2 quarters · filed 2014-02-06
$27.06M
derived: sum of 3 quarters · filed 2014-02-06
$27.06M
10-K · filed 2014-02-06
2011-09-30$14.10M
10-Q · filed 2012-10-25
-$14.10M
10-Q · filed 2011-10-28
$24.00M
derived: sum of 2 quarters · filed 2012-10-25
$24.00M
10-Q · filed 2012-10-25
-$24.00M
10-Q · filed 2011-10-28
$66.79M
derived: sum of 4 quarters · filed 2013-02-05
2011-06-30$9.90M
10-Q · filed 2012-07-24
-$9.90M
10-Q · filed 2011-07-26
$9.90M
10-Q · filed 2012-07-24
-$9.90M
10-Q · filed 2011-07-26
$52.69M
derived: sum of 3 quarters · filed 2013-02-05
$43.79M
derived: sum of 4 quarters · filed 2013-02-05
2011-03-31$0.00
10-Q · filed 2011-04-21
$42.79M
derived: sum of 2 quarters · filed 2013-02-05
$33.89M
derived: sum of 3 quarters · filed 2013-02-05
2010-12-31$42.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05
$33.89M
derived: sum of 2 quarters · filed 2013-02-05
$33.89M
10-K · filed 2013-02-05
-$33.89M
10-K · filed 2011-02-04
2010-09-30-$8.90M
10-Q · filed 2011-10-28
-$8.90M
10-Q · filed 2011-10-28
2009-12-31$5.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03
$2.83M
derived: sum of 2 quarters · filed 2012-02-03
$2.83M
10-K · filed 2012-02-03
-$2.83M
10-K · filed 2010-02-09
2009-09-30-$2.80M
10-Q · filed 2010-10-26
-$2.80M
10-Q · filed 2010-10-26
2008-12-31-$2.82M
10-K · filed 2011-02-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29